Dale G Kern, 727859 Apache Ln, Lehi, UT 84043

7564990, Jul 21, 2009

Aug 18, 2005

11/206671

Dale G. Kern - Hyde Park UT, US
Kurt L. Jensen - Spanish Fork UT, US
Joseph H. Labrum - Orem UT, US
Mark W. Lund - Orem UT, US
Jed G. Morley - Orem UT, US

Nu Skin International, Inc. - Provo UT

G06K 9/00
A01K 43/00

382100, 382274, 356 66

A system for capturing and analyzing images of body features to identify treatments has a base unit with a processor and a display and an image management software component for presenting on the display a user interface to prompt a user to capture images in preselected locations on a body and to receive captured image data. The system has at least two light sources under control of the user interface that provide light following first and second light paths from the respective light sources to the plane of an imaging station, each light path having a significant portion of its light on the plane of the imaging station at a grazing angle of about ten to about thirty degrees. The first and second light paths when projected onto the plane of the imaging station intersect at an angle of at least sixty degrees. An image sensor receives light from the light sources that is reflected from the surface of a body feature located at the imaging station and produces pixel image data representing the body feature. A rating software component receives the pixel image data from the image sensor and is configured to mimic the judgment of a dermatologist to provide a rating vector representing the condition of three or more attributes of the body feature represented by the pixel image data.

D661811, Jun 12, 2012

Dec 14, 2009

29/351904

Scott B. Ferguson - Highland UT, US
Dale G. Kern - Hyde Park UT, US
Bruno Gimelli - Zollikofen, CH

NSE Products, Inc. - Provo UT

2803

D24200

2005022, Oct 13, 2005

Feb 2, 2005

11/049585

Dale Kern - Hyde Park UT, US

A61K035/78

424753000

Methods for the prevention or treatment of disorders and complications of disorders resulting from cell damage caused by an aging-related isoform of NADH oxidase (arNOX) are described. The agent for such inhibition comprises processed various extracts, preferably IBR-DORMIN, both alone and in combination with other inhibition agents, including ubiquinones like coenzyme Q. These agents bind arNOX and inhibit the ability of arNOX to generate reactive oxygen species, thereby decreasing the ability of arNOX to generate reactive oxygen species. Such agents, and their methods of administration, as extremely effective as part of anti-aging treatments.

2007007, Apr 5, 2007

Oct 4, 2005

11/243500

Dale Kern - Hyde Park UT, US
Thomas Schultz - Randolph NJ, US
Carsten Smidt - Sandy UT, US

A61K 31/375
A61K 31/355
A61K 31/122
A61K 31/12
A61K 31/07
A61K 31/015

514458000, 514474000, 514690000, 514725000, 514763000

The present invention is a method of stabilizing an antioxidant by adding a carotenoid. According to one embodiment, the method includes stabilizing the antioxidant by reducing oxidation. The method can also include enhancing the beneficial effects of the antioxidant. The antioxidant can be CoQ10. In one aspect of the invention, the carotenoid is a colorless carotenoid.

2007010, May 10, 2007

Jun 29, 2006

11/478210

Dale Kern - Hyde Park UT, US

A61K 36/896
A61K 31/48
A61K 31/205
A61K 31/12

424753000, 514690000, 424725000, 514026000, 514169000, 514554000, 514284000

Methods for the prevention or treatment of disorders and complications of disorders resulting from cell damage caused by an aging-related isoform of NADH oxidase (arNOX) are described. The agent for such inhibition comprises processed various extracts, preferably IBR-DORMIN, both alone and in combination with other inhibition agents, including ubiquinones like coenzyme Q. These agents bind arNOX and inhibit the ability of arNOX to generate reactive oxygen species, thereby decreasing the ability of arNOX to generate reactive oxygen species. Such agents, and their methods of administration, as extremely effective as part of anti-aging treatments.

2007018, Aug 9, 2007

Feb 2, 2007

11/670643

Dale Kern - Hyde Park UT, US

A61N 1/30

604020000

The present invention relates to methods and systems for application of a substance and an electrical current to a biological tissue or surface. In one embodiment, the methods and systems include application of a substance and an electrical current to the surface or tissue such that the transport or absorption of the substance into the surface or tissue is enhanced for a period of time after the electrical current has been removed.

2008017, Jul 24, 2008

Jan 24, 2008

12/019163

Dale Kern - Hyde Park UT, US

A61K 36/896
A61P 43/00

424773

Methods for the prevention or treatment of disorders and complications of disorders resulting from cell damage caused by an aging-related isoform of NADH oxidase (arNOX) are described. The agent for such inhibition comprises processed various extracts, preferably IBR-DORMIN bulb extract, both alone and in combination with other inhibition agents, including ubiquinones like coenzyme Q. These agents bind arNOX and inhibit the ability of arNOX to generate reactive oxygen species, thereby decreasing the ability of arNOX to generate reactive oxygen species. Such agents, and their methods of administration, as extremely effective as part of anti-aging treatments.

2009024, Oct 1, 2009

Mar 28, 2008

12/058201

Dale Kern - Hyde Park UT, US
Christiaan Meadows - Lafayette IN, US

Nu Skin International, Inc. - Provo UT

A61K 8/30
A61K 31/7034
A61K 31/60
A61K 36/31
A61K 36/07
A61K 36/53
A61K 36/28
A61K 36/752
A61P 17/00
A61Q 19/00
A61K 8/97
A61K 36/35
A61K 36/704
A61K 36/23
A61K 36/896
A61K 36/63
A61K 36/899
A61K 31/122

424 59, 514 35, 514159, 424755, 42419515, 424765, 424725, 424736, 424753, 424750, 514691, 514763, 510119

The invention relates to agents for sequestering serum aging factors, and methods for using the same. More particularly, the invention relates to agents termed herein “Naractin” to denote any one of several naturally-occurring arNOX inhibitors either present in powder or capable of augmenting powder to an inhibitory level comparable to that of the fresh extracts, and to methods for using “Naractins” to prevent or treat disorders and complications of disorders resulting from cell damage caused by an aging-related isoform of NADH oxidase (arNOX). In one exemplary embodiment the agents of the invention comprise at least one naturally occurring Naractin. Such naturally occurring naractins are also capable of augmenting the anti-arNOX effect of other naturally occurring arNOX inhibitory agents.